NASDAQ: $XBIT A New Milestone in Clinical Research XBiotech Inc. has announced positive final efficacy results from the investigator-sponsored TASKIN trial. This Phase II clinical study marks a significant step forward in the company’s efforts to evaluate the potential of its therapeutic candidates in a clinical setting. Understanding the TASKIN Trial The TASKIN trial was…